Correlation Between Absci Corp and Immix Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Absci Corp and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Absci Corp and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Absci Corp and Immix Biopharma, you can compare the effects of market volatilities on Absci Corp and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Absci Corp with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Absci Corp and Immix Biopharma.

Diversification Opportunities for Absci Corp and Immix Biopharma

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Absci and Immix is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Absci Corp and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Absci Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Absci Corp are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Absci Corp i.e., Absci Corp and Immix Biopharma go up and down completely randomly.

Pair Corralation between Absci Corp and Immix Biopharma

Given the investment horizon of 90 days Absci Corp is expected to under-perform the Immix Biopharma. In addition to that, Absci Corp is 1.15 times more volatile than Immix Biopharma. It trades about -0.32 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.01 per unit of volatility. If you would invest  168.00  in Immix Biopharma on August 29, 2024 and sell it today you would lose (3.00) from holding Immix Biopharma or give up 1.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Absci Corp  vs.  Immix Biopharma

 Performance 
       Timeline  
Absci Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Absci Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Immix Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immix Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Absci Corp and Immix Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Absci Corp and Immix Biopharma

The main advantage of trading using opposite Absci Corp and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Absci Corp position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.
The idea behind Absci Corp and Immix Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities